Health Talk

  • Most Popular
  • Most Shared

Reuters Showcase

Misleading Snack?

Misleading Snack?

Frito-Lay chips not "all natural": lawsuit.  Full Article 

Truth about Calories

Truth about Calories

Calories count, but not where they come from: study.  Full Article 

Fighting Diseases

Fighting Diseases

Big Pharma donates drugs for neglected diseases.  Full Article 

De-stressing Room

De-stressing Room

San Francisco airport unveils yoga room for travelers.  Full Article 

Benefits of Soy

Benefits of Soy

Study clouds evidence on soy and menopause.  Full Article 

Sun Damage

Sun Damage

More kids seek tans as they age, may raise skin cancer risk.  Full Article 

Take a Dip

Take a Dip

Swimming lowers older adults' blood pressure.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage 

Embryo preservation often works for cancer patients

Related Topics

NEW YORK | Fri Nov 14, 2008 4:43am IST

NEW YORK (Reuters Health) - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate.

The investigators, who presented their findings this week at the 64th annual meeting of the American Society of Reproductive Medicine in San Francisco, recommend this means preserving fertility for cancer patients, because the ovaries are severely compromised by chemotherapy and radiation.

"There have been few data looking at the clinical performance outcome of those few young cancer patients who do seek embryo cryopreservation" before they undergo toxic treatment, presenter Dr. Bo Yu told Reuters Health.

The research team at New York-Presbyterian Hospital/Columbia University Medical Center reviewed the records of 12 patients younger than age 40 (9 with breast cancer and 1 each with colon cancer, rectal cancer, and synovial cell sarcoma) and 48 age-matched control subjects.

The numbers of mature eggs obtained were similar in the two groups (10.8 vs. 9.2), the investigators reported, and the fertilization rates were also comparable (64 percent vs. 67 percent).

"In early stage cancer, there is a window of at least 6 weeks after surgery that allows patients to recover from surgery and has been proven to be a safe waiting period before starting chemotherapy or radiation," Yu noted. "This is the window of opportunity for patients to consider fertility preservation treatments without causing any delay in the start of cancer treatment."

In a second study, the physicians evaluated the effect of chemotherapy on ovarian function in 26 young women with stage I and II breast cancer. The patients were treated with Adriamycin, cyclophosphamide and paclitaxel for 6 months.

Chemotherapy decreased ovarian reserve "rapidly and dramatically." Although hormone levels recovered quickly, with 58 percent of women regaining menstrual function by 52 weeks, all ovarian reserves remained below the normal range.

However, despite the concern of reduced fertility after chemotherapy, "we have documented that pregnancy can occur," the investigators reported.

"One thing we hope to achieve through publishing our research is to increase awareness among physicians and patients of the gonadotoxic effects of chemotherapy," she said. "Physicians should counsel patients newly diagnosed with cancer to consider fertility preservation treatments before...injury occurs."

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.